Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g Vct5 Regulatory News (MIG5)

Share Price Information for Maven I&g Vct5 (MIG5)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 30.40
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 2.00 (6.803%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 30.40
MIG5 Live PriceLast checked at -
Maven Income and Growth VCT 5 is an Investment Trust

To invest in a diversified portfolio of later-stage UK private companies to provide long-term capital appreciation and generate maintainable levels of income for shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

28 Apr 2020 12:12

RNS Number : 1816L
Maven Income and Growth VCT 5 PLC
28 April 2020
 

Maven Income and Growth VCT 5 PLC (the Company) - Result of Annual General Meeting

 

At the 2020 Annual General Meeting of the Company held at the offices of Maven Capital Partners UK LLP, Kintyre House, 205 West George Street, Glasgow G2 2LW on Tuesday, 28 April 2020 at 11.30am, all of the Resolutions put to the Meeting were duly passed.

 

At the record date for the Annual General Meeting, being 24 April 2020, the total number of voting rights in the Company stood at 125,586,158 and the total number of shares in issue were 125,586,158. The Company advises that for the Annual General Meeting, 249 valid proxy appointments were made in respect of 9,562,054 shares and that the number of proxy votes lodged for each Resolution were as follows:

 

Resolutions

For

Discretion

Against

Withheld

Total

1

To receive the Annual Report and audited Financial Statements

9,275,415

286,639

0

0

9,562,054

2

To approve the Directors' Remuneration Report

8,790,859

286,639

242,952

241,604

9,562,054

3

To approve the Directors' Remuneration Policy

8,769,154

304,787

243,509

244,604

9,562,054

4

To approve a final dividend

9,161,507

316,235

71,115

13,197

9,562,054

5

To re-elect Mr G Humphries as a Director

9,103,332

311,416

118,559

28,747

9,562,054

6

To re-elect Mr C Young as a Director

9,176,280

311,416

50,636

23,722

9,562,054

7

To elect Mr G Miller as a Director

9,152,854

311,416

42,872

54,912

9,562,054

8

To re-appoint Deloitte LLP as Auditor

8,885,236

283,000

388,473

5,345

9,562,054

9

To authorise the Directors to fix the remuneration of the Auditor

9,220,396

307,777

28,536

5,345

9,562,054

10

To authorise the Directors to allot new shares

8,827,030

310,924

322,198

101,902

9,562,054

11

To authorise disapplication of pre-emption rights

8,589,297

300,402

559,470

112,885

9,562,054

12

To authorise the Company to purchase its own shares

8,579,237

275,625

692,093

15,099

9,562,054

13

To allow a general meeting to be called on not less than 14 days' notice

9,031,580

283,000

247,474

0

9,562,054

 

A vote withheld is not a vote in law and any such votes have not been included in the votes for or against the respective Resolutions. The voting figures will be available to view at: www.mavencp.com/migvct5.

 

A copy of the Resolutions which require to be filed at Companies House have also been submitted to the National Storage Mechanism and will shortly be available for inspection at:

https://www.fca.org.uk/markets/primary-markets/regulatory-disclosures/national-storage-mechanism

 

Issued on behalf of the Board

Maven Capital Partners UK LLP, Secretary

28 April 2020

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGIPMBTMTBTBMM
Date   Source Headline
5th Apr 20243:49 pmRNSIssue of Equity
27th Mar 202410:31 amRNSIssue of Equity
22nd Mar 20244:25 pmRNSStatement re Offer for Subscription
22nd Mar 202410:14 amRNSIssue of Supplementary Prospectus
20th Mar 20243:48 pmRNSUnaudited Net Asset Value
8th Mar 20242:57 pmRNSAnnual Financial Report
15th Feb 20244:45 pmRNSTransaction in Own Shares
8th Feb 202410:33 amRNSDirector/PDMR Shareholding
8th Feb 202410:12 amRNSIssue of Equity
7th Feb 20243:09 pmRNSDividend Declaration
19th Dec 20233:28 pmRNSIssue of Equity
18th Dec 20235:24 pmRNSUnaudited Net Asset Value
9th Nov 20233:51 pmRNSResult of General Meeting
20th Oct 20234:13 pmRNSTransaction in Own Shares
13th Oct 20234:56 pmRNSPublication of a Prospectus
4th Oct 20234:03 pmRNSNet Asset Value(s)
29th Aug 20239:15 amRNSDirectorate Change
24th Jul 202311:16 amRNSHalf-year Report
21st Jul 20234:43 pmRNSTransaction in Own Shares
21st Jul 20239:48 amRNSIssue of Equity
17th Jul 202310:57 amRNSNet Asset Value - Dividend Investment Scheme
11th Jul 20234:47 pmRNSNet Asset Value
6th Jul 20234:01 pmRNSStatement re Intended Offers for Subscription
14th Jun 202310:33 amRNSDividend Declaration
2nd Jun 20239:48 amRNSIssue of Equity
5th May 202310:23 amRNSIssue of Equity - Dividend Investment Scheme
27th Apr 20233:57 pmRNSTransaction in Own Shares
27th Apr 20231:04 pmRNSIssue of Supplementary Prospectus
26th Apr 202311:39 amRNSNet Asset Value - Dividend Investment Scheme
25th Apr 20233:14 pmRNSNet Asset Value(s)
25th Apr 202312:50 pmRNSResult of AGM
5th Apr 202312:32 pmRNSIssue of Equity
29th Mar 20232:19 pmRNSIssue of Supplementary Prospectus
23rd Mar 20235:18 pmRNSAnnual Financial Report
3rd Mar 20239:56 amRNSIssue of Equity
21st Feb 20234:44 pmRNSTransaction in Own Shares
8th Feb 202310:24 amRNSDirector/PDMR Shareholding
8th Feb 20239:48 amRNSIssue of Equity
1st Feb 20233:25 pmRNSUnaudited NAV and Proposed Final Dividend
9th Nov 20223:02 pmRNSResult of General Meeting
4th Nov 20223:25 pmRNSTransaction in Own Shares
26th Oct 20223:53 pmRNSTransaction in Own Shares
7th Oct 20224:28 pmRNSPublication of a Prospectus
4th Oct 20223:30 pmRNSChange of Auditor
4th Oct 20221:35 pmRNSNet Asset Value(s)
26th Aug 202210:14 amRNSIssue of Equity
22nd Aug 20229:36 amRNSStatement re Dividend Investment Scheme
11th Aug 20224:47 pmRNSTransaction in Own Shares
25th Jul 20227:00 amRNSHalf-year Report
12th Jul 202212:40 pmRNSUnaudited Net Asset Value and Dividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.